FIGURE 1.

Analysis of TCGA data set showed that MUC12 levels were positively correlated with RCC progression. A, MUC12 was up‐regulated in RCC patients compared to normal kidney tissues. B‐C, MUC12 was poor prognostic factor for RCC overall survival (B) and disease‐free survival (C). D, MUC12 was up‐expression in high clinical stage, pathological grade, tumour recurrence and tumour metastasis RCC. E, ROC curve revealed that MUC12 could be as a worse prognostic indicator (95% CI: 0.592‐0.680, P < 0.001) for RCC patients. F‐G, Univariate (F) and multivariate (G) analysis showed that MUC12 was an independent risk factor for overall survival, tumour recurrence, tumour grade and cancer metastasis. *P < 0.05